Home > Research > Publications & Outputs > RETRACTED EBSRMF: Ensemble Based Similarity-Reg...

Electronic data

Links

Text available via DOI:

View graph of relations

RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses. / Shahzad, Muhammad; Tahir, Muhammad Atif; Khan, M. Atta et al.
In: Journal of Intelligent and Fuzzy Systems, Vol. 43, No. 3, 21.07.2022, p. 3443-3452.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Shahzad, M, Tahir, MA, Khan, MA, Jiang, R & Shams, RA 2022, 'RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses', Journal of Intelligent and Fuzzy Systems, vol. 43, no. 3, pp. 3443-3452. https://doi.org/10.3233/jifs-212867

APA

Shahzad, M., Tahir, M. A., Khan, M. A., Jiang, R., & Shams, R. A. (2022). RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses. Journal of Intelligent and Fuzzy Systems, 43(3), 3443-3452. https://doi.org/10.3233/jifs-212867

Vancouver

Shahzad M, Tahir MA, Khan MA, Jiang R, Shams RA. RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses. Journal of Intelligent and Fuzzy Systems. 2022 Jul 21;43(3):3443-3452. Epub 2022 Apr 20. doi: 10.3233/jifs-212867

Author

Shahzad, Muhammad ; Tahir, Muhammad Atif ; Khan, M. Atta et al. / RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses. In: Journal of Intelligent and Fuzzy Systems. 2022 ; Vol. 43, No. 3. pp. 3443-3452.

Bibtex

@article{acd13c6aad504af881ce50e5a06692a3,
title = "RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses",
abstract = "Drug sensitivity prediction to a panel of cancer cell lines using computational approaches has been a challenge for two decades. With the emergence of high-throughput screening technologies, thousands of compounds and cancer cell lines panels with drug sensitivity data are publicly available at various pharmacogenomics databases. Analyzing these data is crucial to improve cancer treatment and develop new anticancer drugs. In this work, we propose EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization, which is a bagging based framework to improve the drug sensitivity prediction on the Cancer Cell Line Encyclopedia (CCLE) data. Based on the fact that similar drugs and cell lines exhibit similar drug response, we have investigated cell line and drug similarity matrices based on gene expression profiles and chemical structure respectively. The drug sensitivity value is used as outcome values which are the half maximal inhibitory concentrations (IC50). In order to improve the generalization ability of the proposed model, a homogeneous ensemble based bagging learning approach is also investigated where multiple SRMF models are used to train N subsets of the input data. The outcome of each training algorithm is aggregated using the averaging method to predict the outcome. Experiments are conducted on two benchmark datasets: CCLE and GDSC. The proposed model is compared with state-of-the-art models using multiple evaluation metrics including Root Means Square Error (RMSE) and Pearson Correlation Coefficient (PCC). The proposed model is quite promising and achieves better performance on CCLE dataset when compared with the existing approaches.",
keywords = "Drug sensiyivity, Matrix factorization, cancer, ensemble learning, keyword five",
author = "Muhammad Shahzad and Tahir, {Muhammad Atif} and Khan, {M. Atta} and Richard Jiang and Shams, {Rauf Ahmed}",
year = "2022",
month = jul,
day = "21",
doi = "10.3233/jifs-212867",
language = "English",
volume = "43",
pages = "3443--3452",
journal = "Journal of Intelligent and Fuzzy Systems",
issn = "1064-1246",
publisher = "IOS Press",
number = "3",

}

RIS

TY - JOUR

T1 - RETRACTED EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization to Predict Anticancer Drug Responses

AU - Shahzad, Muhammad

AU - Tahir, Muhammad Atif

AU - Khan, M. Atta

AU - Jiang, Richard

AU - Shams, Rauf Ahmed

PY - 2022/7/21

Y1 - 2022/7/21

N2 - Drug sensitivity prediction to a panel of cancer cell lines using computational approaches has been a challenge for two decades. With the emergence of high-throughput screening technologies, thousands of compounds and cancer cell lines panels with drug sensitivity data are publicly available at various pharmacogenomics databases. Analyzing these data is crucial to improve cancer treatment and develop new anticancer drugs. In this work, we propose EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization, which is a bagging based framework to improve the drug sensitivity prediction on the Cancer Cell Line Encyclopedia (CCLE) data. Based on the fact that similar drugs and cell lines exhibit similar drug response, we have investigated cell line and drug similarity matrices based on gene expression profiles and chemical structure respectively. The drug sensitivity value is used as outcome values which are the half maximal inhibitory concentrations (IC50). In order to improve the generalization ability of the proposed model, a homogeneous ensemble based bagging learning approach is also investigated where multiple SRMF models are used to train N subsets of the input data. The outcome of each training algorithm is aggregated using the averaging method to predict the outcome. Experiments are conducted on two benchmark datasets: CCLE and GDSC. The proposed model is compared with state-of-the-art models using multiple evaluation metrics including Root Means Square Error (RMSE) and Pearson Correlation Coefficient (PCC). The proposed model is quite promising and achieves better performance on CCLE dataset when compared with the existing approaches.

AB - Drug sensitivity prediction to a panel of cancer cell lines using computational approaches has been a challenge for two decades. With the emergence of high-throughput screening technologies, thousands of compounds and cancer cell lines panels with drug sensitivity data are publicly available at various pharmacogenomics databases. Analyzing these data is crucial to improve cancer treatment and develop new anticancer drugs. In this work, we propose EBSRMF: Ensemble Based Similarity-Regularized Matrix Factorization, which is a bagging based framework to improve the drug sensitivity prediction on the Cancer Cell Line Encyclopedia (CCLE) data. Based on the fact that similar drugs and cell lines exhibit similar drug response, we have investigated cell line and drug similarity matrices based on gene expression profiles and chemical structure respectively. The drug sensitivity value is used as outcome values which are the half maximal inhibitory concentrations (IC50). In order to improve the generalization ability of the proposed model, a homogeneous ensemble based bagging learning approach is also investigated where multiple SRMF models are used to train N subsets of the input data. The outcome of each training algorithm is aggregated using the averaging method to predict the outcome. Experiments are conducted on two benchmark datasets: CCLE and GDSC. The proposed model is compared with state-of-the-art models using multiple evaluation metrics including Root Means Square Error (RMSE) and Pearson Correlation Coefficient (PCC). The proposed model is quite promising and achieves better performance on CCLE dataset when compared with the existing approaches.

KW - Drug sensiyivity

KW - Matrix factorization

KW - cancer

KW - ensemble learning

KW - keyword five

U2 - 10.3233/jifs-212867

DO - 10.3233/jifs-212867

M3 - Journal article

VL - 43

SP - 3443

EP - 3452

JO - Journal of Intelligent and Fuzzy Systems

JF - Journal of Intelligent and Fuzzy Systems

SN - 1064-1246

IS - 3

ER -